Journey Medical (DERM) Share-based Compensation (2020 - 2026)
Journey Medical (DERM) posted Share-based Compensation of $989000.0 for Q1 2026, down 44.28% on a QoQ basis from $1.8 million in Q4 2025, and down 25.25% year-over-year from $1.3 million in Q1 2025.
Journey Medical (DERM) Share-based Compensation (2020 - 2026) Analysis & Trends
Journey Medical's Share-based Compensation history runs 7 years deep, the most recent figure standing at $989000.0 for Q1 2026.
- Quarterly Share-based Compensation fell 25.25% year-over-year to $989000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 1.23% YoY) and the FY2025 annual result came in at $6.3 million, down 30.33% from the prior year.
- Share-based Compensation was $989000.0 for Q1 2026 at Journey Medical, down from $1.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $2.5 million in Q2 2025 and bottomed at $529000.0 in Q4 2023.
- A 5-year average of $1.3 million and a median of $1.4 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation surged 17875.0% — and 2023, when it tumbled 63.26%.
- Journey Medical's Share-based Compensation stood at $1.4 million in 2022, then tumbled by 63.26% to $529000.0 in 2023, then jumped by 160.49% to $1.4 million in 2024, then advanced by 28.81% to $1.8 million in 2025, then sank by 44.28% to $989000.0 in 2026.
- Business Quant data shows DERM's Share-based Compensation at $989000.0 in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | 989,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 989,000.00 |
| Mar 31, 2026 | 989,000.00 |
| Dec 31, 2025 | 1.78 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 529,000.00 |
| Dec 31, 2023 | 529,000.00 |